In conclusion, these findings uncover a critical role of GPR17 in the OL defects that are observed in neurodevelopmental disorders and suggest that modulation of its signaling might be a potential therapeutic approach for treating these conditions. The gene discussed is GPR17; the disease is neurodevelopmental disorder.